Trelegy ellipta 200-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FN3TA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,734
Award facts
- Contract value 100% obligated
- $43,733.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $43,733.92 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination inhalant medication used to treat chronic obstructive pulmonary disease. Issued on August 11, 2025, with completion expected by August 12, 2025, this firm fixed-price contract represents a direct procurement with no set-aside designation. The award was made to AmerisourceBergen's Corporate Office division, with performance occurring at the company's Conshohocken, Pennsylvania headquarters. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through competitive award processes. The parent IDC represents a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The delivery order fulfills DLA's pharmaceutical supply requirements, supporting the military medical supply chain with essential respiratory medications for service members and military healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FN3TA?
SPE2DB25FN3TA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FN3TA worth?
The government has obligated $43,734 on SPE2DB25FN3TA.
Is contract SPE2DB25FN3TA an order under another contract?
Yes. SPE2DB25FN3TA is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3TA competed?
The extent of competition for SPE2DB25FN3TA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award